Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study.
The outcome for diffuse large B-cell lymphoma (DLBCL) patients has improved with the immunochemotherapy combination R-CHOP. An increased rate of heart failure is well documented following th...